Results 1 to 10 of about 22,235 (205)
Prevalence, predictors and outcome of pulmonary mucormycosis in COVID-19 associated rhino orbital mucormycosis in a tertiary care centre in south India [PDF]
Current Medical Mycology, 2023 Background and Purpose: India witnessed an explosive rise in mucormycosis following COVID-19 infection. While rhino orbital mucormycosis was the most common presentation, pulmonary mucormycosis was closely followed.
Karthigeyan Thanjavur Sethuraman +3 more
doaj +1 more source
Rise of Mucormycosis during the COVID-19 Pandemic and the Challenges Faced [PDF]
Current Medical Mycology, 2023 Mucormycosis (previously called zygomycosis) is a diverse group of increasingly recognized and frequently fatal mycotic diseases caused by members of the class zygomycetes. Mucormycosis is around 80 times more common in India, compared to other developed
Malavika Kottarathil +3 more
doaj +1 more source
Mucormycosis and COVID-19: A systemic review
Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022 COVID-19 presents severely in persons with immunocompromised states such as diabetes mellitus. Steroids are used in the management of COVID-19.
Ankit Kaushik +3 more
doaj +1 more source
A rare case of post-COVID mucormycosis of the kidney
Current Medicine Research and Practice, 2022 Post-COVID mucormycosis of the kidney is a rare phenomenon with only very few cases reported, worldwide. Among the various opportunistic fungal infections, mucormycosis is associated with the highest mortality.
Ankit Tyagi +3 more
doaj +1 more source
COVID-19 associated mucormycosis in Assiut University Hospitals: a multidisciplinary dilemma
Scientific Reports, 2022 Mucormycosis is a life-threatening opportunistic angioinvasive fungal infection. We aimed to describe the frequency, presentations, predictors, and in-hospital outcome of mucormycosis patients in the scope of CoronaVirusDisease-19 (COVID-19) during the ...
Sahar Farghly Youssif +12 more
doaj +1 more source
Rhino-orbital Mucormycosis in a COVID-19 Patient: The First Case in Malaysia
Proceedings of Singapore Healthcare, 2022 Mucormycosis is an aggressive and potentially fatal fungal infection caused by fungi of the order Mucorales. There has been an increase in the number of cases of rhino-orbital mucormycosis in people with COVID-19, particularly in India.
Chee Yik Chang +3 more
doaj +1 more source
Asian Journal of Medical Sciences, 2022 Background: With recent surge in SARS-COVID-19, cases of rhinocerebral mucormycosis are on rise. Rapid diagnosis of mucormycosis is essential as delay in the treatment is associated with dreadful outcome.
Amruta Patil +3 more
doaj +1 more source
Key molecules of Mucorales for COVID-19-associated mucormycosis: a narrative review
Journal of Bio-X Research, 2022 Mucormycosis is a lethal human disease caused by fungi of the order Mucorales. Mucormycosis is caused by fungi mainly belonging to the genera Mucor, Rhizopus, and Lichtheimia, all of which belong to the order Mucorales.
Priyanka Baberwal +3 more
doaj +1 more source
Effectiveness of COVID-19 Vaccination against COVID -associated Mucormycosis [PDF]
Journal of Clinical and Diagnostic Research, 2022 Introduction: Coronavirus Disease-2019 (COVID-19) infections may be associated with a wide range of opportunistic bacterial and fungal co-infections. Both Aspergillus and Candida have been reported as the main fungal pathogens for co-infection in people ...
Rohit Mahla, Saurabh Shrivastava
doaj +1 more source
Mucormycosis following COVID19: clinical case and literature review [PDF]
Клиническая микробиология и антимикробная химиотерапия, 2021 Mucormycosis is one of the most aggressive invasive mycoses. The mortality rate of patients with mucormycosis, depending on clinical form and background disease, varies from 30% to 100%.
Khostelidi S.N. +7 more
doaj +1 more source